|
⚲
|
| Keyboard |
| Nicholas Simon | |
|---|---|
| Firm | Clarus Ventures LLC |
| Address | c/o Clarus Ventures, LLC 101 Main Street, Suite 1210 Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Clarus Ventures LLC | |||||
| Clarus IV-A LP | 021-286937 | Executive Officer | 789.7 M of 880.0 M |
217.3 M | |
| Clarus IV-B LP | 021-286939 | Executive Officer | 789.7 M of 880.0 M |
139.5 M | |
| Clarus IV-C LP | 021-286940 | Executive Officer | 789.7 M of 880.0 M |
257.5 M | |
| Clarus IV-D LP | 021-286941 | Executive Officer | 789.7 M of 880.0 M |
51.4 M | |
| Clarus Defined Exit I LP | 021-222299 | Executive Officer | 100.0 M of 100.0 M |
63.9 M | |
| Clarus de II LP | 021-224951 | Executive Officer | 40.0 M of 40.0 M |
26.8 M | |
| Clarus Lifesciences III LP | 021-211426 | Executive Officer | 234.2 M of 375.0 M |
24.8 M | |
| Clarus Ventures III GP LP | 021-225116 | Executive Officer | of 50.0 M |
||
| Pearl Therapeutics Inc | 021-186914 | Director | 23.3 M of 66.1 M |
||
| Pearl Therapeutics Inc | 021-186913 | Director | 13.3 M of 14.3 M |
||
| Pearl Therapeutics Inc | 021-150714 | Director | 37.5 M of 69.9 M |
||
| Achillion Pharmaceuticals Inc | 021-146800 | Director | 50.1 M of 50.1 M |
||